Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effect of Occlusal Splint and Botulinum Toxin Therapies on Masseter Muscle Thickness and Pain Levels on Bruxism Patients

NCT06593821 is registered in ClinicalTrials.gov with Zonguldak Bulent Ecevit University as lead sponsor.

NCT NCT06593821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06593821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effect of Occlusal Splint and Botulinum Toxin Therapies on Masseter Muscle Thickness and Pain Levels on Bruxism Patients
Lead sponsor
Zonguldak Bulent Ecevit University
Phase
Not applicable
Overall status
Completed
Start date
April 3, 2023
Completion date
January 19, 2024
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bruxism, masseter muscle hypertrophy